A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer.

Rudy S Suidan; Caryn M St Clair; Stephen J Lee; Joyce N Barlin; Kara C Long Roche; Edward J Tanner; Yukio Sonoda; Richard R Barakat; Oliver Zivanovic; Dennis S Chi

首页> 外文期刊>Gynecologic Oncology: An International Journal >A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer.

【24h】

A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer.

机译：最佳切除的晚期卵巢癌中原发性腹膜内化疗与巩固性腹膜内化疗的比较。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

In our study, primary IV/IP chemotherapy was associated with improved OS compared to IV followed by consolidation IP chemotherapy in patients with optimally cytoreduced advanced EOC.

机译：在我们的研究中，对于具有最佳细胞减少的晚期EOC的患者，与IV相比，初次IV / IP化疗与OS改善相关，随后是巩固IP化疗。

著录项

来源
《Gynecologic Oncology: An International Journal》 |2014年第3期|共5页
作者
Rudy S Suidan; Caryn M St Clair; Stephen J Lee; Joyce N Barlin; Kara C Long Roche; Edward J Tanner; Yukio Sonoda; Richard R Barakat; Oliver Zivanovic; Dennis S Chi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. [J] . Rudy S Suidan, Caryn M St Clair, Stephen J Lee, Gynecologic Oncology: An International Journal . 2014,第3期

机译：最佳切除的晚期卵巢癌中原发性腹膜内化疗与巩固性腹膜内化疗的比较。
2. Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer. [J] . Nicoletto MO, Dalla Palma M, Donach ME, Tumori. . 2010,第6期

机译：在经过充分预处理的患有次优残留卵巢癌和原发性腹膜癌的患者中，进行腹膜内化疗和静脉内化疗的积极经验。
3. Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center (vol 142, pg 13, 2016) [J] . Schlappe Brooke A., Mueller Jennifer J., Zivanovic Oliver, Gynecologic Oncology: An International Journal . 2016,第1期

机译：引用了在腹膜内高化疗利用中心对III期卵巢癌进行最佳细胞减灭后使用腹膜内初次化疗的差异的理由（第142卷，2016年第13页）
4. 45 Cases of Surgical Treatment of Ovarian Cancer and Analysis on Effect of Intraperitoneal Chemotherapy [C] . Bao Lihong, Sa Qila, Sun Ping, International Conference on Applied Science, Engineering and Technology . 2017

机译：卵巢癌手术治疗45例及腹膜内化疗分析
5. Nanoparticle depot for intraperitoneal chemotherapy of ovarian cancer. [D] . Sun, Bo. 2016

机译：用于卵巢癌腹膜内化疗的纳米颗粒贮库。
6. Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center [O] . Brooke A. Schlappe, Jennifer J. Mueller, Oliver Zivanovic, -1

机译：在腹膜内化疗高利用率中心对Ⅲ期卵巢癌进行最佳细胞减少后采用原发性腹膜内化疗的差异的理由
7. Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” Gynecol. Oncol. 142 (2016) 13–18 [O] . Brooke A. Schlappe, Jennifer J. Mueller, Oliver Zivanovic, 2016

机译：在高腹膜化疗利用中心的III阶段卵巢癌的最佳腹膜内癌症中使用初级腹膜内化疗的差异差异的勘探性勘探官员“Gynecol。 oncol。 142（2016）13-18

A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer.

摘要

著录项

相似文献

相关主题

期刊订阅